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ABSTRACT
Introduction: There are many factors responsible for the development of metabolic syndrome – mainly 
associated with lifestyle, but also genetic ones. MC4R (melanocortin 4 receptor) genes variants have 
been associated with the risk of developing obesity, type 2 diabetes mellitus and coronary artery disease. 
Aim of the study: To investigate the association between MC4R rs17782313 polymorphism and concen-
trations of glucose, insulin, HOMA-IR and QUICKI values in the whole study group.
Materials and methods: Study group consisted of 294 patients (136 men and 158 women). Collected 
venous blood samples were stored at -700C until the study group was completed. In the laboratory of 
Clinical Hospital 1 in Zabrze, the DNA materials were isolated, proper concentration of the DNA (15 ng/μL) 
were prepared and quality and quantity were checked by spectrophotometry. Allelic discrimination was 
performed with the use of fluorescent-labelled TaqMan Pre-designed SNP Genotyping Assay probes. 
Results: No statistically significant differences in concentrations of cholesterol, HDL, LDL, TG between 
genotypes in women and men were observed. In the whole group of patients, glucose and insulin levels 
did not differ significantly between TT, CT and CC carriers. Significant differences in values of HOMA-IR and 
QUICKI between TT, CT and CC carriers as well as between TT carriers and CT+CC carriers were found. 
CC+TT carriers have a significantly lower value of HOMA-IR and higher QUICKI value than TT carriers. 
Conclusions: MC4R polymorphism in rs17782313 may be associated with insulin resistance. Further 
studies are necessary to completely assess the association between investigated polymorphism, insulin 
resistance and risk of diabetes mellitus development.
Key words: melanocortin 4 receptor, insulin resistance, diabetes mellitus, single nucleotide polymorphism, 
QUICKI, HOMA-IR
Med Res J 2021; 6 (2): 94–98
Medical Research Journal 2021;
Volume 6, Number 2, 94–98
DOI: 10.5603/MRJ.a2021.0023




Abdominal obesity, insulin resistance, raised blood 
pressure, reduced serum concentration of high-den-
sity lipoprotein and elevated serum concentration of 
triglycerides are gathered as metabolic syndrome, 
which is closely linked to a high risk of developing 
cardiovascular diseases and diabetes mellitus. The 
development of metabolic syndrome is associated both 
with environmental and genetic factors which influence 
obesity, glucose and insulin metabolism1. Prevalence 
depends on gender, age socioeconomic status, and 
ethnic group. Many studies reported that one of the 
most important factors necessary for metabolic syn-
drome development is abdominal obesity [1]. Due 
to the rising prevalence of obesity, the prevalence of 
metabolic syndrome also increases dramatically; it is 
estimated that 34% of women and 50% of men have 
MS in Poland [2]. The main cause of insulin resistance, 
which leads to hyperglycaemia, is an increased level 
of plasma fatty acids released from adipose tissue [1]. 
Thus, new markers involved in metabolic syndrome 
development are still being sought. MC4R (melano-
cortin 4 receptor) is the G-protein coupled receptor 
that binds Pro-opiomelanocortin (POMC)-derived 
melanocortin peptides and transmits satiety signal in 
the paraventricular nucleus [3]. Its gene is located on 
the long arm of chromosome 18. MC4R is considered 
an important regulator of food intake and metabolism 
which dysfunction may be associated with the develop-
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ment of obesity, insulin resistance, type 2 diabetes and 
coronary artery disease [4]. Many SNP near the MC4R 
gene are reported to be associated with an increased 
risk of obesity [5, 6]. 
Insulin resistance (IR) is described as a disorder in the 
regulation of glucose homeostasis which is manifested 
by decreased insulin ability to reduce serum glucose lev-
el despite its normal or increased level in serum [7]. This 
pathological condition is caused by decreased sensitivity 
of muscles, adipose tissue, liver, and other body tissues 
to insulin [7]. The insulin sensitivity resistance is often 
assessed using Homeostasis Model Assessment — In-
sulin Resistance (HOMA-IR). To assess insulin sensitivity 
which is the inverse of insulin resistance the quantitative 
insulin sensitivity check index (QUICKI) is used [7]. 
The study aimed to investigate the association 
between different variants of the MC4R gene in 
rs17782313 and serum concentrations of glucose, 
insulin, HDL, LDL, TG, HOMA-IR and QUICKI values 




294 study samples of whole blood were collected. 
Inclusion criteria contained: age > 18 years, no tumour, 
no dialysis at the time of sampling and informed consent. 
Patients were included in the study by a random selection. 
Evaluation of DNA levels
Whole blood samples were collected for the exam-
ination, then isolated by column method. Afterwards, 
they were stored until the study group was collected. 
The concentration of genetic material 15 ng/μL was 
obtained by mixing DNA with water according to the 
dilution protocol and checked with a denoviX spectro-
photometer. 
Preparation of samples
Preparation for PCR included: preparation of the 
mixture by vortexing on a short spin probe, mixing with 
water, buffer and mix (reaction mix to Roche device), 
re-vortexing, centrifugation. The solution was mixed with 
the DNA and transported to the PCR plate. PCR reaction 
was performed by Roche Lightcycler 96. Alleles were 
marked as A in VIC and G in FAM (Tab. 1).
Statistical analysis
The Shapiro-Wilk test was used to assess the 
data distribution. Variables data are presented as 
mean ± SD. The significance between distributions 
of genotypes and alleles, gender, the occurrence of 
hypertension, coronary artery disease (MIC), diabetes 
mellitus, cigarettes smoking was tested using Pearson’s 
c2 test. To compare valuable data between the three 
groups (genotypes TT, CT and CC), the Kruskal-Wallis 
test with multiple comparisons was performed. To 
compare valuable data between two groups (groups 
TT, CT+CC) Mann-Whitney U test was performed. 
Concentrations of cholesterol, HDL, LDL, TG were 
analysed separately for women and men. Levels of 
glucose, insulin, values of HOMA-IR and QUICKI were 
analysed for the whole study group.
Results
No statistically significant differences were found in 
concentrations of cholesterol, HDL, LDL, TG between 
genotypes in groups of women and men (Tab. 2, 3). 
In the whole group of patients, glucose and insulin 
levels did not differ significantly between TT, CT and CC 
carriers (Tab. 4). Significant differences in values of HO-
MA-IR and QUICKI between TT, CT and CC carriers as well 
as between TT carriers and CT+CC carriers were found. 
CC+CT carriers have a significantly lower value of HO-
MA-IR and higher QUICKI value than TT carriers (Fig. 1, 2).
Discussion
Many studies reported a significant association 
between MC4R SNP in rs17782313 and parameters of 
metabolic syndrome, however, the results were often 
inconclusive. Research conducted by Brodowski et 
al. revealed that the probability of MS development in 
a group of postmenopausal women is higher in individ-
uals with the CT or CC genotype in rs17782313. Wom-
en with CT or CC genotype had higher levels of TG, 
total cholesterol, LDL-C and Apolipoprotein B than 
those with TT genotype8. On the contrary, the study 
carried out by Szkup et al. reported that MC4R SNP in 
rs17782313 is not linked to a higher risk of metabolic 
syndrome development in a group of 45–60-year-old 
women [9]. H. Yarizadeh et al. showed that in the pop-
ulation of overweighted or obese Iranian women the 
presence of allele C in rs17782313 is associated with 
higher HOMA-IR value and elevated insulin level [10]. 
Contrary to these results, the presented study found 
significantly higher HOMA-IR value in patients with TT 
genotype compared to TC and CC individuals. The 
differences in HOMA-IR and QUICKI value between 
genotypes were insignificant in the study conducted by 
Brodowski [8] and not assessed in research conducted 
by Szkup [9]. The authors assume that the presence 
of allele T is associated with increased HOMA-IR value 
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Table 1. Characteristic of study group (n = 294)
                                          Genotype
 TT CT CC p
 n % n % n %
Gender       0.253
Women 103 63.58% 53 32.72% 2 1.23%
Men 85 61.59% 45 32.61% 6 4.35%
Hypertension       0.46039
Yes 96 65.75% 44 30.14% 5 3.42%
No 92 59.74% 54 35.06% 3 1.95%
MIC       0.34531
Yes 31 63.27% 15 30.61% 3 6.12%
No 157 62.55% 83 33.07% 5 199.20%
Diabetes mellitus       0.36361
Yes 21 70.00% 9 30.00% 0 0.00%
No 167 61.85% 89 32.96% 8 2.96%
Nicotinism       0.66682
Yes 41 57.75% 26 36.62% 2 2.82%
No 147 64.19% 72 31.44% 6 2.62%
 mean SD mean SD mean SD p
Age 53,66 16.84 51.26 16.92 58.88 18.01 0.1929
BMI 26,80 3.70 26.49 4.03 25.18 1.77 0.2554





































TT CT + CC
Figure 1. Comparison of HOMA-IR value between TT carriers 
(wild genotype) and CC or CT carriers (p = 0,036, n = 294)
HOMA-IR — homeostasis model assessment-insulin
Figure 2. Comparison of QUICKI value between TT carriers 
(wild genotype) and CC or CT carriers (p = 0,018, n = 294)
QUICKI — quantitative insulin sensitivity check index
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                                                       Women
TT CT CC p
mean SD mean SD mean SD
Cholesterol 6.05 1.16 6.46 1.21 6.58 0.57 0.1747
HDL 1.34 0.35 1.44 0.30 1.23 0.86 0.1946
LDL 4.09 1.04 4.45 1.13 4.90 0.21 0.1179
TG 1.37 0.80 1.24 0.54 1.00 0.18 0.461
HDL — high-density lipoprotein, LDL — low-density lipoprotein, MC4R — melanocortin 4 receptor, TG — triacylglycerols
Table 3. MC4R rs17782313 polymorphism and cholesterol, HDL, LDL, TG levels in men (n = 142)
 
 
  Men     
p
 
TT  CT  CC  
mean SD mean SD mean SD
Cholesterol 5.88 1.31 6.14 1.51 6.83 1.84 0.3323
HDL 1.15 0.33 1.29 0.43 1.22 0.21 0.2822
LDL 4.11 1.17 4.27 1.23 4.82 1.31 0.3405
TG 1.41 0.96 1.67 1.89 1.54 1.14 0.9505
HDL — high-density lipoprotein, LDL — low-density lipoprotein, MC4R — melanocortin 4 receptor, TG — triacylglycerols
Table 4. MC4R rs17782313 polymorphism and concentrations of glucose, insulin, HOMA-IR and QUICKI values in the 
whole study group (n = 294)
 
 
TT CT CC p
mean SD mean SD mean SD
Glucose 84.81 24.16 80.42 16.05 73.25 10.94 0.0891
Insulin 13.06 9.74 11.39 5.72 7.98 3.49 0.0364
HOMA-IR 2.51 1.39 2.31 1.43 1.42 0.62 0.0135
QUICKI 0.60 0.10 0.62 0.12 0.69 0.09 0.0079
HOMA-IR — homeostasis model assessment-insulin, MC4R — melanocortin 4 receptor, QUICKI — quantitative insulin sensitivity check index
and insulin resistance, however, the differences in gen-
otype distributions between diabetes and nondiabetic 
patients were insignificant. One must bear in mind that 
other studies tested different models of inheritance, thus 
contradictory results can depend on the used model. 
This study used the dominant model of the MC4R 
rs17782313 inheritance (TT, CT+CC). 
In the presented work no significant association 
between MC4R SNP in rs17782313 and obesity was 
found. This observation is in line with two similar studies 
conducted in Poland [9, 11] and one carried out in the 
Czech Republic [12]. On the contrary, other popula-
tion studies conducted in Pakistan [13] and Greece 
[14] showed that homozygotes CC have a higher risk 
of obesity; similarly, in the Romania population het-
erozygotes CT are more predisposed to obesity [15]. 
It can be supposed that the presence of allele C is 
associated with an increased risk of obesity. However, 
due to differences in research findings, further studies 
are necessary to thoroughly investigate the influence 
of SNP MC4R on the prevalence of overweight and 
obesity. One should also take into account the role of 
population characteristics which can be responsible 
for the lack of association between SNP of MC4R and 
obesity in the Polish population. 
Lipid profile disturbances as a component of met-
abolic syndrome were also analysed in the conducted 
research. Similar to this study, other studies conducted 
in Poland [9, 11] and Greece [14] did not find a statis-
tically significant association between MC4R SNP in 
rs17782313 and the lipid profile of patients. There is 
only one study reporting a reduced risk of lipid distur-
bances among individuals with T allele in a group of 
Polish postmenopausal women [8].
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Some studies demonstrated a relationship between 
MC4R SNP in rs17782313 and glycaemic profile – fast-
ing blood glucose and insulin level. Yarizadeh et al. 
showed significantly higher insulin level in CT or CC 
carriers in comparison to TT carriers [10]. However, 
a similar study conducted by Lazopoulou et al. in 
the Greek population did not reveal the association 
between MC4R SNP in rs17782313 and insulin or 
glucose level [14]. This research has found no associ-
ation between investigated SNP and glucose or insulin 
concentration. 
The most significant results of this study concern 
the statistical association between the parameters 
measuring insulin resistance (HOMA-IR and QUICKI) 
and the studied SNP. In the studied population of 
women aged 45–60, no correlation was found between 
this parameter and metabolic syndrome [9]. Further 
studies in both genders are necessary to confirm or 
rule out the association between insulin resistance 
and MC4R SNP.
Conclusion
The obtained results showed that SNP in 
rs17782313 of MC4R gene is not significantly associated 
with lipid profile disturbances which are characteristic 
of metabolic syndrome. However, statistically significant 
differences in HOMA-IR and QUICKI value may suggest 
an influence of investigated SNP on insulin resistance. 
TT genotype was present more often in patients with 
increased insulin resistance while CT and CC genotypes 
were associated with decreased insulin resistance and 
higher insulin sensitivity. No statistically significant 
association between studied SNP and occurrence of 
hypertension, coronary artery disease and diabetes 
mellitus was observed. Further studies with a larger 
number of patients are needed to clarify the role of 
SNP in rs17782313 of MC4R gene in the pathogenesis 
of metabolic syndrome and insulin resistance which is 
closely related to this disorder.
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